Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $475.40 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agiliti Surgical, Inc. | $163.20 | 1 | $0 (2018) |
| Novo Nordisk Inc | $114.15 | 5 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $76.22 | 3 | $0 (2022) |
| Janssen Biotech, Inc. | $54.65 | 4 | $0 (2023) |
| Ardelyx, Inc. | $33.87 | 2 | $0 (2024) |
| Lilly USA, LLC | $16.98 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.57 | 4 | Novo Nordisk Inc ($29.01) |
| 2023 | $60.61 | 4 | Janssen Biotech, Inc. ($26.09) |
| 2022 | $137.38 | 7 | Vanda Pharmaceuticals Inc. ($76.22) |
| 2019 | $54.64 | 1 | Novo Nordisk Inc ($54.64) |
| 2018 | $163.20 | 1 | Agiliti Surgical, Inc. ($163.20) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Obesity | ||||||
| 02/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Obesity | ||||||
| 11/07/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Immunology | ||||||
| 10/18/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Obesity | ||||||
| 02/28/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Immunology | ||||||
| 01/31/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Neuroscience | ||||||
| 10/04/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Immunology | ||||||
| 09/12/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 06/01/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Immunology | ||||||
| 05/09/2022 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: SCHIZOPHRENIA | ||||||
| 05/05/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
| 03/21/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.92 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $54.64 | General |
| Category: Diabetes | ||||||
| 02/17/2018 | Agiliti Surgical, Inc. | — | Food and Beverage | Cash or cash equivalent | $163.20 | General |
| Category: Ultrasound | ||||||
About Dr. Charles Mooney, MD
Dr. Charles Mooney, MD is a Occupational Medicine healthcare provider based in Clarion, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104817105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Mooney, MD has received a total of $475.40 in payments from pharmaceutical and medical device companies, with $59.57 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($475.40).
Practice Information
- Specialty Occupational Medicine
- Location Clarion, IA
- Active Since 10/31/2005
- Last Updated 12/26/2019
- Taxonomy Code 2083X0100X
- Entity Type Individual
- NPI Number 1104817105
Products in Payments
- Ozempic (Drug) $54.64
- HETLIOZ (Drug) $52.55
- Wegovy (Drug) $43.89
- STELARA (Biological) $39.28
- IBSRELA (Drug) $33.87
- FANAPT (Drug) $23.67
- EMGALITY (Drug) $16.98
- JARDIANCE (Drug) $16.33
- Rybelsus (Drug) $15.62
- REMICADE (Biological) $15.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.